|
|
|
|
|
Legal status
Patent in force
| (51) | INT.CL. | C07D 215/56 | (2006.01) |
| C07B 59/00 | (2006.01) | ||
| A61K 31/47 | (2006.01) | ||
| A61P 11/12 | (2006.01) |
| (11) | Number of the document | 2709986 |
| (13) | Kind of document | T |
| (96) | European patent application number | 12725197.3 |
| Date of filing the European patent application | 2012-05-17 | |
| (97) | Date of publication of the European application | 2014-03-26 |
| (45) | Date of publication and mention of the grant of the patent | 2017-03-22 |
| (46) | Date of publication of the claims translation | 2017-05-25 |
| (86) | Number | PCT/US2012/038297 |
| Date | 2012-05-17 |
| (87) | Number | WO 2012/158885 |
| Date | 2012-11-22 |
| (30) | Number | Date | Country code |
| 201161487497 P | 2011-05-18 | US |
| (72) |
MORGAN, Adam, J., US
|
| (73) |
Vertex Pharmaceuticals (Europe) Limited,
2 Kingdom Street, London W2 6BD,
GB
|
| (74) |
Stanislava TELEIŠIENĖ,
UAB "Brainera", Taikos 235-17, LT-05213 Vilnius,
LT
|
| (54) | Ivakaftoro deuterinti dariniai |
| DEUTERATED DERIVATIVES OF IVACAFTOR |
| Payment date | Validity (years) | Amount | |
| 2025-05-05 | 14 | 289.00 EUR |
| 2026-05-17 |